Haoxiangni Health Food Co.,Ltd. (SHE:002582)
China · Delayed Price · Currency is CNY 10.19
+0.17 (1.70%)
Aug 25, 2026, 12:14 PM CST
Haoxiangni Health Food Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,421 | 4,774 | 3,615 | 3,476 | 4,215 | 3,856 | |
Market Cap Growth | -1.24% | 32.06% | 3.99% | -17.53% | 9.31% | -40.81% |
Enterprise Value | 4,319 | 4,405 | 2,812 | 1,954 | 2,926 | 1,853 |
Last Close Price | 10.02 | 10.46 | 7.16 | 5.59 | 6.84 | 6.17 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 2.66 | 5.51 | - | - | - | 62.57 |
Forward PE | - | 39.17 | 39.17 | 39.17 | 39.17 | 39.17 |
PS Ratio | 3.28 | 3.60 | 2.20 | 2.01 | 3.01 | 3.01 |
PB Ratio | 0.99 | 1.21 | 1.02 | 0.85 | 1.01 | 0.87 |
P/TBV Ratio | 1.01 | 1.23 | 1.05 | 0.87 | 1.03 | 0.89 |
P/FCF Ratio | - | - | - | 10.12 | - | - |
P/OCF Ratio | 134.48 | 42.09 | 41.56 | 8.04 | - | 55.02 |
PEG Ratio | - | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 3.20 | 3.32 | 1.72 | 1.13 | 2.09 | 1.45 |
EV/EBITDA Ratio | 63.77 | 74.60 | - | 78.89 | - | 145.46 |
EV/FCF Ratio | - | - | - | 5.69 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.23 | 0.20 | 0.22 | 0.22 | 0.13 | 0.12 |
Debt / EBITDA Ratio | 15.38 | 10.09 | 62.90 | 15.73 | - | 13.97 |
Debt / FCF Ratio | - | - | - | 2.64 | - | - |
Net Debt / Equity Ratio | -0.01 | -0.08 | -0.19 | -0.22 | -0.31 | -0.39 |
Net Debt / EBITDA Ratio | -1.25 | -5.52 | 47.91 | -36.67 | 8.64 | -136.13 |
Net Debt / FCF Ratio | 0.99 | 136.10 | 17.83 | -2.64 | 4.67 | 13.91 |
Asset Turnover | 0.24 | 0.25 | 0.31 | 0.32 | 0.26 | 0.22 |
Inventory Turnover | 3.35 | 2.49 | 3.20 | 2.44 | 1.87 | 1.94 |
Quick Ratio | 0.82 | 1.54 | 1.68 | 2.55 | 3.07 | 3.54 |
Current Ratio | 1.21 | 2.11 | 2.12 | 3.15 | 4.18 | 4.55 |
Return on Equity (ROE) | 43.23% | 23.11% | -1.98% | -1.36% | -4.70% | 1.11% |
Return on Assets (ROA) | -0.73% | -0.67% | -1.50% | -1.01% | -3.10% | -1.01% |
Return on Invested Capital (ROIC) | -1.08% | -1.32% | -4.19% | -2.88% | -9.55% | -3.01% |
Return on Capital Employed (ROCE) | -1.20% | -1.20% | -3.20% | -1.80% | -5.80% | -2.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 36.88% | 18.14% | -1.99% | -1.49% | -4.49% | 1.60% |
FCF Yield | -1.56% | -0.05% | -1.05% | 9.89% | -6.61% | -3.23% |
Dividend Yield | 5.67% | 5.74% | 19.55% | 10.74% | 1.46% | 1.62% |
Payout Ratio | 17.11% | 52.11% | - | - | - | 782.63% |
Buyback Yield / Dilution | 10.31% | 3.71% | -4.00% | 1.83% | 7.09% | 5.62% |
Total Shareholder Return | 15.98% | 9.45% | 15.54% | 12.57% | 8.55% | 7.24% |